Cargando…
Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation
Multiple sclerosis is an autoimmune disease of the central nervous system. Yet, the autoimmune targets are still undefined. The extracellular e1 sequence of KCNJ10, the inwardly rectifying potassium channel 4.1, has been subject to fierce debate for its role as a candidate autoantigen in multiple sc...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994600/ https://www.ncbi.nlm.nih.gov/pubmed/36910419 http://dx.doi.org/10.1093/braincomms/fcad044 |
_version_ | 1784902650135838720 |
---|---|
author | Nicot, Arnaud B Harb, Jean Garcia, Alexandra Guillot, Flora Mai, Hoa-Le Mathé, Camille V Morille, Jérémy Vallino, Amélie Dugast, Emilie Shah, Sita P Lefrère, Fabienne Moyon, Mélinda Wiertlewski, Sandrine Le Berre, Ludmilla Renaudin, Karine Soulillou, Jean-Paul van Pesch, Vincent Brouard, Sophie Berthelot, Laureline Laplaud, David-Axel |
author_facet | Nicot, Arnaud B Harb, Jean Garcia, Alexandra Guillot, Flora Mai, Hoa-Le Mathé, Camille V Morille, Jérémy Vallino, Amélie Dugast, Emilie Shah, Sita P Lefrère, Fabienne Moyon, Mélinda Wiertlewski, Sandrine Le Berre, Ludmilla Renaudin, Karine Soulillou, Jean-Paul van Pesch, Vincent Brouard, Sophie Berthelot, Laureline Laplaud, David-Axel |
author_sort | Nicot, Arnaud B |
collection | PubMed |
description | Multiple sclerosis is an autoimmune disease of the central nervous system. Yet, the autoimmune targets are still undefined. The extracellular e1 sequence of KCNJ10, the inwardly rectifying potassium channel 4.1, has been subject to fierce debate for its role as a candidate autoantigen in multiple sclerosis. Inwardly rectifying potassium channel 4.1 is expressed in the central nervous system but also in peripheral tissues, raising concerns about the central nervous system-specificity of such autoreactivity. Immunization of C57Bl6/J female mice with the e1 peptide (amino acids 83–120 of Kir4.1) induced anti-e1 immunoglobulin G- and T-cell responses and promoted demyelinating encephalomyelitis with B cell central nervous system enrichment in leptomeninges and T cells/macrophages in central nervous system parenchyma from forebrain to spinal cord, mostly in the white matter. Within our cohort of multiple sclerosis patients (n = 252), 6% exhibited high anti-e1 immunoglobulin G levels in serum as compared to 0.7% in the control cohort (n = 127; P = 0.015). Immunolabelling of inwardly rectifying potassium channel 4.1-expressing white matter glia with the anti-e1 serum from immunized mice increased during murine autoimmune neuroinflammation and in multiple sclerosis white matter as compared with controls. Strikingly, the mouse and human anti-e1 sera labelled astrocytoma cells when N-glycosylation was blocked with tunicamycin. Western blot confirmed that neuroinflammation induces Kir4.1 expression, including its shorter aglycosylated form in murine experimental autoencephalomyelitis and multiple sclerosis. In addition, recognition of inwardly rectifying potassium channel 4.1 using mouse anti-e1 serum in Western blot experiments under unreduced conditions or in cells transfected with the N-glycosylation defective N104Q mutant as compared to the wild type further suggests that autoantibodies target an e1 conformational epitope in its aglycosylated form. These data highlight the e1 sequence of inwardly rectifying potassium channel 4.1 as a valid central nervous system autoantigen with a disease/tissue-specific post-translational antigen modification as potential contributor to autoimmunity in some multiple sclerosis patients. |
format | Online Article Text |
id | pubmed-9994600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-99946002023-03-09 Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation Nicot, Arnaud B Harb, Jean Garcia, Alexandra Guillot, Flora Mai, Hoa-Le Mathé, Camille V Morille, Jérémy Vallino, Amélie Dugast, Emilie Shah, Sita P Lefrère, Fabienne Moyon, Mélinda Wiertlewski, Sandrine Le Berre, Ludmilla Renaudin, Karine Soulillou, Jean-Paul van Pesch, Vincent Brouard, Sophie Berthelot, Laureline Laplaud, David-Axel Brain Commun Original Article Multiple sclerosis is an autoimmune disease of the central nervous system. Yet, the autoimmune targets are still undefined. The extracellular e1 sequence of KCNJ10, the inwardly rectifying potassium channel 4.1, has been subject to fierce debate for its role as a candidate autoantigen in multiple sclerosis. Inwardly rectifying potassium channel 4.1 is expressed in the central nervous system but also in peripheral tissues, raising concerns about the central nervous system-specificity of such autoreactivity. Immunization of C57Bl6/J female mice with the e1 peptide (amino acids 83–120 of Kir4.1) induced anti-e1 immunoglobulin G- and T-cell responses and promoted demyelinating encephalomyelitis with B cell central nervous system enrichment in leptomeninges and T cells/macrophages in central nervous system parenchyma from forebrain to spinal cord, mostly in the white matter. Within our cohort of multiple sclerosis patients (n = 252), 6% exhibited high anti-e1 immunoglobulin G levels in serum as compared to 0.7% in the control cohort (n = 127; P = 0.015). Immunolabelling of inwardly rectifying potassium channel 4.1-expressing white matter glia with the anti-e1 serum from immunized mice increased during murine autoimmune neuroinflammation and in multiple sclerosis white matter as compared with controls. Strikingly, the mouse and human anti-e1 sera labelled astrocytoma cells when N-glycosylation was blocked with tunicamycin. Western blot confirmed that neuroinflammation induces Kir4.1 expression, including its shorter aglycosylated form in murine experimental autoencephalomyelitis and multiple sclerosis. In addition, recognition of inwardly rectifying potassium channel 4.1 using mouse anti-e1 serum in Western blot experiments under unreduced conditions or in cells transfected with the N-glycosylation defective N104Q mutant as compared to the wild type further suggests that autoantibodies target an e1 conformational epitope in its aglycosylated form. These data highlight the e1 sequence of inwardly rectifying potassium channel 4.1 as a valid central nervous system autoantigen with a disease/tissue-specific post-translational antigen modification as potential contributor to autoimmunity in some multiple sclerosis patients. Oxford University Press 2023-02-22 /pmc/articles/PMC9994600/ /pubmed/36910419 http://dx.doi.org/10.1093/braincomms/fcad044 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Nicot, Arnaud B Harb, Jean Garcia, Alexandra Guillot, Flora Mai, Hoa-Le Mathé, Camille V Morille, Jérémy Vallino, Amélie Dugast, Emilie Shah, Sita P Lefrère, Fabienne Moyon, Mélinda Wiertlewski, Sandrine Le Berre, Ludmilla Renaudin, Karine Soulillou, Jean-Paul van Pesch, Vincent Brouard, Sophie Berthelot, Laureline Laplaud, David-Axel Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation |
title | Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation |
title_full | Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation |
title_fullStr | Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation |
title_full_unstemmed | Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation |
title_short | Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation |
title_sort | aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (kcnj10) provides a target for autoimmune neuroinflammation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994600/ https://www.ncbi.nlm.nih.gov/pubmed/36910419 http://dx.doi.org/10.1093/braincomms/fcad044 |
work_keys_str_mv | AT nicotarnaudb aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT harbjean aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT garciaalexandra aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT guillotflora aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT maihoale aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT mathecamillev aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT morillejeremy aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT vallinoamelie aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT dugastemilie aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT shahsitap aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT lefrerefabienne aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT moyonmelinda aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT wiertlewskisandrine aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT leberreludmilla aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT renaudinkarine aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT soulilloujeanpaul aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT vanpeschvincent aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT brouardsophie aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT berthelotlaureline aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation AT laplauddavidaxel aglycosylatedextracellularloopofinwardlyrectifyingpotassiumchannel41kcnj10providesatargetforautoimmuneneuroinflammation |